A novel pan-Nox inhibitor, APX-115, protects kidney injury in streptozotocin-induced diabetic mice: possible role of peroxisomal and mitochondrial biogenesis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kwon, Guideock | - |
dc.contributor.author | Uddin, Md Jamal | - |
dc.contributor.author | Lee, Gayoung | - |
dc.contributor.author | Jiang, Songling | - |
dc.contributor.author | Cho, Ahreum | - |
dc.contributor.author | Lee, Jung Hwa | - |
dc.contributor.author | Lee, Sae Rom | - |
dc.contributor.author | Bae, Yun Soo | - |
dc.contributor.author | Moon, Sung Hwan | - |
dc.contributor.author | Lee, Soo Jin | - |
dc.contributor.author | Cha, Dae Ryong | - |
dc.contributor.author | Ha, Hunjoo | - |
dc.date.available | 2020-11-02T08:21:45Z | - |
dc.date.issued | 2017-09-26 | - |
dc.identifier.issn | 1949-2553 | - |
dc.identifier.issn | 1949-2553 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/4623 | - |
dc.description.abstract | NADPH oxidase (Nox)-derived reactive oxygen species (ROS) are increasingly recognized as a key factor in inflammation and extracellular matrix accumulation in diabetic kidney disease. APX-115 (3-phenyl-1-(pyridin-2-yl)-4-propyl-1-5-hydroxypyrazol HCl) is a novel orally active pan-Nox inhibitor. The objective of this study was to compare the protective effect of APX-115 with a renin-angiotensin system inhibitor (losartan), the standard treatment against kidney injury in diabetic patients, on streptozotocin (STZ)-induced diabetic kidney injury. Diabetes was induced by intraperitoneal injection of STZ at 50 mg/kg/day for 5 days in C57BL/6J mice. APX-115 (60 mg/kg/day) or losartan (1.5 mg/kg/day) was administered orally to diabetic mice for 12 weeks. APX-115 effectively prevented kidney injury such as albuminuria, glomerular hypertrophy, tubular injury, podocyte injury, fibrosis, and inflammation as well as oxidative stress in diabetic mice, similar to losartan. In addition, both APX-115 and losartan treatment effectively inhibited mitochondrial and peroxisomal dysfunction associated with lipid accumulation. Our data suggest that APX-115, a pan-Nox inhibitor, may become a novel therapeutic agent against diabetic kidney disease by maintaining peroxisomal and mitochondrial fitness. | - |
dc.format.extent | 16 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | IMPACT JOURNALS LLC | - |
dc.title | A novel pan-Nox inhibitor, APX-115, protects kidney injury in streptozotocin-induced diabetic mice: possible role of peroxisomal and mitochondrial biogenesis | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.18632/oncotarget.18540 | - |
dc.identifier.scopusid | 2-s2.0-85030100536 | - |
dc.identifier.wosid | 000411760400072 | - |
dc.identifier.bibliographicCitation | ONCOTARGET, v.8, no.43, pp 74217 - 74232 | - |
dc.citation.title | ONCOTARGET | - |
dc.citation.volume | 8 | - |
dc.citation.number | 43 | - |
dc.citation.startPage | 74217 | - |
dc.citation.endPage | 74232 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.subject.keywordPlus | OXIDATIVE STRESS | - |
dc.subject.keywordPlus | NADPH OXIDASE | - |
dc.subject.keywordPlus | NAD(P)H OXIDASE | - |
dc.subject.keywordPlus | RENAL INJURY | - |
dc.subject.keywordPlus | DB/DB MICE | - |
dc.subject.keywordPlus | PODOCYTE INJURY | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | NEPHROPATHY | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | COMPLICATIONS | - |
dc.subject.keywordAuthor | APX-115 | - |
dc.subject.keywordAuthor | diabetic kidney disease | - |
dc.subject.keywordAuthor | mitochondria and peroxisome | - |
dc.subject.keywordAuthor | oxidative stress | - |
dc.subject.keywordAuthor | pan-Nox inhibitor | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.